Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Mototaka Hayashi
Bevacizumab Monotherapy for Temozolomide-Refractory Malignant Glioma
Japanese Journal of Neurosurgery
Surgery
Neurology
Related publications
The Strategy for Enhancing Temozolomide Against Malignant Glioma
Frontiers in Oncology
Cancer Research
Oncology
Impact of Temozolomide on Immune Response During Malignant Glioma Chemotherapy
Clinical and Developmental Immunology
Gene Therapy for Malignant Glioma
Molecular and Cellular Therapies
Gene Therapy for Malignant Glioma
Japanese Journal of Neurosurgery
Surgery
Neurology
MicroRNA-93 Promotes the Malignant Phenotypes of Human Glioma Cells and Induces Their Chemoresistance to Temozolomide
Biology Open
Biochemistry
Agricultural
Genetics
Molecular Biology
Biological Sciences
Addition of Lomustine for Bevacizumab-Refractory Recurrent Glioblastoma
Acta Oncologica
Nuclear Medicine
Radiology
Hematology
Oncology
Medicine
Imaging
Phase II Study of Bevacizumab and Vorinostat for Patients With Recurrent World Health Organization Grade 4 Malignant Glioma
Oncologist
Cancer Research
Medicine
Oncology
Polifeprosan 20, 3.85% Carmustine Slow-Release Wafer in Malignant Glioma: Evidence for Role in Era of Standard Adjuvant Temozolomide
Core Evidence
Medicine
Reviews
References
Pharmacology
PLK1 Inhibition Targets Myc-Activated Malignant Glioma Cells Irrespective of Mismatch Repair Deficiency-Mediated Acquired Resistance to Temozolomide
Molecular Cancer Therapeutics
Cancer Research
Oncology